Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22

Mol Biol Cell. 1999 Jul;10(7):2441-59. doi: 10.1091/mbc.10.7.2441.

Abstract

Gas3/PMP22 plays a crucial role in regulating myelin formation and maintenance, and different genetic alterations in gas3/PMP22 are responsible for a set of human peripheral neuropathies. We have previously demonstrated that Gas3/PMP22 could regulate susceptibility to apoptosis in NIH3T3 cells but not in REF 52 cells. In this report we demonstrate that when the apoptotic response triggered by gas3/PMP22 was counteracted by Bcl-2 coexpression, morphological changes were observed. Time-lapse analysis confirmed that Gas3/PMP22 can modulate cell spreading, and this effect was strengthened after inhibition of phosphoinositide 3-kinase. Using the active form of the small GTPase RhoA, we have been able to dissect the different Gas3/PMP22 biological activities. RhoA counteracted the Gas3/PMP22-dependent morphological response but was unable to neutralize the apoptotic response. Treatment of NIH3T3 cells with cytotoxic necrotizing factor 1, which activates endogenous Rho, also counteracted Gas3/PMP22-mediated cell shape and spreading changes. Treatment of REF 52 cells, which are unresponsive to Gas3/PMP22 overexpression, with the C3 exoenzyme, inhibiting Rho activity, renders REF 52 cells responsive to Gas3/PMP22 overexpression for cell shape and spreading changes. Finally, assembly of stress fibers and focal adhesions complexes, in response to lysophosphatidic acid-induced endogenous Rho activation, was impaired in Gas3/PMP22-overexpressing cells. We hypothesize that cell shape and spreading regulated by Gas3/PMP22 through the Rho GTPase might have an important role during Schwann cells differentiation and myelinization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3 Cells / drug effects
  • 3T3 Cells / metabolism
  • Adaptation, Physiological
  • Androstadienes / pharmacology
  • Animals
  • Apoptosis / physiology*
  • Bacterial Toxins / pharmacology
  • Cell Differentiation
  • Cell Movement / drug effects
  • Cell Movement / genetics*
  • Cell Size / drug effects
  • Charcot-Marie-Tooth Disease / genetics
  • Cytotoxins / pharmacology
  • Escherichia coli Proteins*
  • GTP-Binding Proteins / metabolism*
  • Gene Expression Regulation
  • Humans
  • Lipopolysaccharides / pharmacology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism*
  • Mice
  • Mutation
  • Myelin Proteins / genetics
  • Myelin Proteins / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Schwann Cells / metabolism
  • Schwann Cells / pathology
  • Stress, Physiological
  • Time Factors
  • Wortmannin
  • rhoA GTP-Binding Protein

Substances

  • Androstadienes
  • Bacterial Toxins
  • Cytotoxins
  • Escherichia coli Proteins
  • Lipopolysaccharides
  • Membrane Proteins
  • Myelin Proteins
  • PMP22 protein, human
  • Pmp22 protein, mouse
  • Proto-Oncogene Proteins c-bcl-2
  • cytotoxic necrotizing factor type 1
  • GTP-Binding Proteins
  • rhoA GTP-Binding Protein
  • Wortmannin

Grants and funding